BMS-986094

Star0

DB11966InvestigationalSmall molecule

INX-08189 has been used in trials studying the treatment of Hepatitis C, HCV (Genotype 1), and Hepatitis C Virus.

Mechanism: Pharmacologically active on RNA-directed RNA polymerase
Curator reviewed
Formula / weight: C₃₀H₃₉N₆O₉P · 658.649 g/mol (avg)
Code names: BMS-986094

Resolves to

Compound

UNII62F4AD749YCAS1234490-83-5ChEMBLCHEMBL1209734PubChem46700744

Structure

InChIKeyYFXGICNMLCGLHJ-RSKRLRQZSA-NSMILESCOC1=C2N=CN([C@@H]3O[C@H](COP(=O)(N[C@@H](C)C(=O)OCC(C)(C)C)OC4=C5C=CC=CC5=CC=C4)[C@@H](O)[C@@]3(C)O)C2=NC(N)=N1

Targets

O39930NS5bP26664Genome polyprotein

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with BMS-986094, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account